See what questions
a doctor would ask.
A new drug (GVAX) which is currently undergoing the trial process is proving that it can decrease residual cancer cells in acute myelogenous leukemia patients following chemotherapy. Trial results showed that 69% of subjects and reduced blood cancer cells and 60% had reduced bone marrow cancer cells. The drug is currently being tested for its efficacy on patients with multiple myeloma, prostate cancer, lung cancer and pancreatic cancer.
Source: summary of medical news story as reported by Forbes
About: New drug proving effective in reducing cancer cells following chemotherapy
Date: 7 December 2004
http:/ This summary article refers to the following medical categories:
Related Medical Topics
More News Topics
This summary article refers to the following medical categories:
Search Specialists by State and City